Pages that link to "Q28555167"
Jump to navigation
Jump to search
The following pages link to Metformin Improves Ileal Epithelial Barrier Function in Interleukin-10 Deficient Mice (Q28555167):
Displayed 10 items.
- The stress polarity pathway: AMPK 'GIV'-es protection against metabolic insults (Q37715482) (← links)
- AMP-activated protein kinase: a therapeutic target in intestinal diseases. (Q41567299) (← links)
- Metformin protects against intestinal barrier dysfunction via AMPKα1-dependent inhibition of JNK signalling activation. (Q47100569) (← links)
- Is Metformin Poised for a Second Career as an Antimicrobial? (Q47561333) (← links)
- AMPK improves gut epithelial differentiation and barrier function via regulating Cdx2 expression. (Q51124364) (← links)
- The stress polarity signaling (SPS) pathway serves as a marker and a target in the leaky gut barrier: implications in aging and cancer (Q89636468) (← links)
- The absence of interleukin 10 affects the morphology, differentiation, granule content and the production of cryptidin-4 in Paneth cells in mice (Q90060090) (← links)
- Metformin effect on gut microbiota: insights for HIV-related inflammation (Q90194896) (← links)
- Reciprocal Association between the Apical Junctional Complex and AMPK: A Promising Therapeutic Target for Epithelial/Endothelial Barrier Function? (Q91645103) (← links)
- Control of Inflammation by Calorie Restriction Mimetics: On the Crossroad of Autophagy and Mitochondria (Q92441593) (← links)